The ascending rank of chronic kidney disease in the global burden of disease study
- PMID: 28201666
- DOI: 10.1093/ndt/gfw330
The ascending rank of chronic kidney disease in the global burden of disease study
Abstract
General population-based studies, the chronic kidney disease (CKD) prognosis consortium and renal registries worldwide have contributed to the description of the scale of CKD as a public health problem. Since 1990, CKD has been included in the list of non-communicable diseases investigated by the Global Burden of Disease (GBD) study. The GBD represents a systematic, high-quality, scientific effort to quantify the comparative magnitude of health loss from all major diseases, injuries and risk factors. This article provides an outline of the place of CKD in the ranking of these diseases and the change over time. Whereas age-standardized death and disability-adjusted life years (DALYs) rates due to non-communicable diseases in general have been declining, such favourable trends do not exist for CKD. Altogether the GBD reports indicate increasing rates for death and DALYs due to CKD with huge variation across the globe. A substantial component of the observed increase in mortality attributable to CKD relates to that caused by diabetes mellitus and hypertension. For the increase in DALYs, CKD due to diabetes mellitus appears to be the main contributor. It is possible that these trends are in part due to new data becoming available or different coding behaviour over time, including greater specificity of coding. Although some feel there is evidence of overdiagnosis, it seems clear that in many regions CKD and its risk factors are a growing public health problem and in some of them rank very high as cause of years of life lost and DALYs. Therefore, public health policies to address this problem as well as secondary prevention in high-risk groups remain greatly needed.
Keywords: CKD; death rates; disability-adjusted life years; prevalence; years of life lost.
© The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
Similar articles
-
Dissonant health transition in the states of Mexico, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Lancet. 2016 Nov 12;388(10058):2386-2402. doi: 10.1016/S0140-6736(16)31773-1. Epub 2016 Oct 5. Lancet. 2016. PMID: 27720260
-
Burden of chronic kidney diseases and underlying causes in Zambia: evidence from the global burden of disease study 2019.BMC Nephrol. 2023 Feb 18;24(1):39. doi: 10.1186/s12882-023-03078-5. BMC Nephrol. 2023. PMID: 36800948 Free PMC article.
-
Changes in the US Burden of Chronic Kidney Disease From 2002 to 2016: An Analysis of the Global Burden of Disease Study.JAMA Netw Open. 2018 Nov 2;1(7):e184412. doi: 10.1001/jamanetworkopen.2018.4412. JAMA Netw Open. 2018. PMID: 30646390 Free PMC article.
-
Global burden of disease in young people aged 10-24 years: a systematic analysis.Lancet. 2011 Jun 18;377(9783):2093-102. doi: 10.1016/S0140-6736(11)60512-6. Epub 2011 Jun 7. Lancet. 2011. PMID: 21652063 Review.
-
Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010.Glob Heart. 2014 Mar;9(1):145-158.e21. doi: 10.1016/j.gheart.2013.12.008. Glob Heart. 2014. PMID: 25432124 Review.
Cited by
-
The scientific principles and technological determinants of haemodialysis membranes.Clin Kidney J. 2021 Dec 27;14(Suppl 4):i5-i16. doi: 10.1093/ckj/sfab184. eCollection 2021 Dec. Clin Kidney J. 2021. PMID: 34987782 Free PMC article. Review.
-
Overview of the burden of chronic kidney disease in Mexico: secondary data analysis based on the Global Burden of Disease Study 2017.BMJ Open. 2020 Mar 25;10(3):e035285. doi: 10.1136/bmjopen-2019-035285. BMJ Open. 2020. PMID: 32213523 Free PMC article.
-
Comparison of shared decision making in patients undergoing hemodialysis and peritoneal dialysis for choosing a dialysis modality.BMC Nephrol. 2021 Feb 23;22(1):67. doi: 10.1186/s12882-021-02269-2. BMC Nephrol. 2021. PMID: 33622265 Free PMC article.
-
Identifying classification systems regarding vascular access for haemodialysis: protocol for a scoping review.BMJ Open. 2022 Dec 29;12(12):e064842. doi: 10.1136/bmjopen-2022-064842. BMJ Open. 2022. PMID: 36581414 Free PMC article.
-
Unveiling the therapeutic potential of berberine: its therapeutic role and molecular mechanisms in kidney diseases.Front Pharmacol. 2025 Feb 21;16:1549462. doi: 10.3389/fphar.2025.1549462. eCollection 2025. Front Pharmacol. 2025. PMID: 40061955 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical